The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2020

Filed:

Aug. 15, 2016
Applicant:

Tufts Medical Center, Inc., Boston, MA (US);

Inventors:

Navin K. Kapur, Hanover, MA (US);

Richard H. Karas, Franklin, MA (US);

Assignee:

Tufts Medical Center, Inc., Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 25/10 (2013.01); A61B 5/00 (2006.01); A61B 5/0215 (2006.01); A61B 5/024 (2006.01); A61B 5/026 (2006.01); A61B 5/042 (2006.01); A61M 1/10 (2006.01); A61M 1/12 (2006.01); A61B 17/12 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61M 25/10184 (2013.11); A61B 5/026 (2013.01); A61B 5/0215 (2013.01); A61B 5/02438 (2013.01); A61B 5/042 (2013.01); A61B 5/6853 (2013.01); A61B 5/6858 (2013.01); A61B 5/746 (2013.01); A61B 17/1204 (2013.01); A61B 17/12036 (2013.01); A61B 17/12109 (2013.01); A61B 17/12136 (2013.01); A61M 1/106 (2013.01); A61M 1/1043 (2014.02); A61M 1/1086 (2013.01); A61M 1/125 (2014.02); A61M 1/127 (2013.01); A61B 17/12172 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00044 (2013.01); A61B 2017/00115 (2013.01); A61B 2017/00154 (2013.01); A61B 2017/00199 (2013.01); A61B 2017/00221 (2013.01); A61B 2017/00398 (2013.01); A61B 2017/00411 (2013.01); A61B 2017/00734 (2013.01); A61B 2017/00889 (2013.01); A61M 25/10188 (2013.11); A61M 2025/1052 (2013.01); A61M 2205/3331 (2013.01); A61M 2230/005 (2013.01); A61M 2230/30 (2013.01);
Abstract

Systems and methods and devices are provided for arresting or reversing the effects of myocardial remodeling and degeneration after cardiac injury, without the potential drawbacks associated with previously existing systems and methods, by at least partially occluding flow through the superior vena cava over multiple cardiac cycles, and more preferably, by adjusting the interval or degree of occlusion responsive to a sensed level of patient activity. In some embodiments, a controller is provided that actuates a drive mechanism responsive to a sensed level of patient activity to provide at least partial occlusion of the patient's superior vena cava, while a data transfer circuit of the controller provides bi-directional transfer of physiologic data to the patient's smartphone or tablet to permit display and review of such data.


Find Patent Forward Citations

Loading…